Antigen presentation by a macrophage-like cell line persistently infected with respiratory syncytial virus

Virus Research

Volumn 99, Issue 1, 2004, Pages 95-100

  Guerrero Plata, Antonieta ^a,d   Ortega, Enrique ^b   Ortíz Navarrete, Vianney ^c   Gómez, Beatríz ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Antigen presentation; Macrophage like cell line; Respiratory syncytial virus persistence

Indexed keywords

CYTOKINE; FC RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS ANTIGEN;

ANIMAL; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CELL CULTURE; CELL FUNCTION; CELL LINE; CELL SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL INFECTION; GENE; GROWTH, DEVELOPMENT AND AGING; IMMUNE RESPONSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 0346849663     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2003.10.005     Document Type: Conference Paper

References (33)

1. Bangham C.R., McMichael A. Specific Human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9183-9187.
2. Bangham C.R., Openshaw P.J.M., Ball L.A., King A.M.Q., Wertz G.W., Askonas B.A. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N) but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 137:1986;3973-3977.
3. Bossert B., Conzelmann K.K. Respiratory syncytial virus (RSV) non-structural proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J. Virol. 76:2002;4287-4293.
4. Bramley A.M., Vitalis T.Z., Wiggs B.R., Hegele R.G. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea pigs. Eur. Respir. J. 14:1999;1061-1067.
5. Collins, P.L., Chanock, R.M., Murphy, B., 2001. Respiratory syncytial virus. In: Knipe, D., Howley, P. (Eds.), Fields Virology, fourth ed. Lippincott Williams & Wilkins, Philadelphia, pp. 1443-1485.
6. Dakhama A., Vitaliz T.Z., Hegele R.G. Persistent of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Eur. Respir. J. 10:1997;20-26.
7. Delves P.J., Roitt M.I. The immune system. N. Engl. J. Med. 343:2000;108-117.
8. Garofalo R., Mei F., Espejo R., Ye G., Haeberle H., Baron S., Ogra P.L., Reyes V.E. Respiratory syncytial virus infection of human respiratory epithelial cell sup-regulates class I MHC expression through the induction of IFN-a and IL-a. J. Immunol. 157:1997;2506-2513.
9. Gordon, S., 1999. Macrophages and the immune response. In: Paul, W. (Ed.), Fundamental Immunology. Lippincott Raven, Philadelphia, pp. 533-545.
10. Guerrero-Plata A., Ortega E., Gómez B. Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production. Viral Immunol. 14:2001;19-30.
11. + T cells in the development of airway hyperresponsiveness in a murine model of airway sensitization. J. Exp. Med. 183:1996;1719-1729.
12. Hegele R.G., Hyashi S., Bramley A.M., Hogg J.C. Persistence of respiratory syncytial virus genome and protein after bronchiolitis in guinea pig. Chest. 105:1994;1848-1854.
13. Kimpen J.L.L. Viral infections and childhood asthma. Am. J. Respir. Crit. Care Med. 162:2000;S108-S112.
14. Kimpen J.L.L. Respiratory syncytial virus and asthma: the role of monocytes. Am. J. Respir. Crit. Care Med. 163:2001;S7-S9.
15. Openshaw P.J.M., Anderson K., Wertz G.W., Askonas B.A. The 22. KDa protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection J. Virol. 64:1990;1683-1689.
16. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1995;1357-1367.
17. Openshaw P.J.M., Gillan S.D., Culley F.J. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr. Infect. Dis. J. 22:2003;S58-S65.
18. Pemberton R.M., Cannon M.J., Openshaw P.J.M., Ball L.A., Wertz G.W., Askonas B.A. Cytotoxic T cells specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J. Gen. Virol. 68:1987;2177-2182.
19. Piedimonte G. The association between respiratory syncytial virus infection and reactive airway disease. Respir. Med. 96:2002;S25-S29.
20. Piedimonte G., Simoes E.A.F. Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian Knot? Eur. Respir. J. 20:2002;515-517.
21. Poulter L.W., Janossy G., Power C., Sreenan S., Burke C. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol. Today. 15:1994;258-261.
22. Pullan C.R., Hey E.N. Wheezing, asthma and pulmonary functions 10 years after infection with respiratory syncytial virus in infancy. Br. Med. J. 284:1982;1665-1669.
23. Riedel F., Oberdieck B., Streckert H.I., Philippou S., Krusat T., Marek W. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea pigs. Eur. Respir. J. 10:1997;639-645.
24. Ritter M., Huber J., Aubock H., Pöhl-Markl J., Troppmair M., Herold A., Gächter W., Nussbaumer G., Böch D., Nachbauer U., Westhoff B., Eibl H., Schweigerhof J., Thaler H., Grosse-Wilde N., Niederweise D. Lysis susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen-expression and cytokine-induced activation status. Immunology. 81:1994;569-577.
25. Sarmiento R.E., Tirado R., Gomez B. Characteristics of a respiratory syncyctial virus persistently infected macrophage-like culture. Virus Res. 84:2002;45-58.
26. + T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J. Immunol. 162:1999;4207-4211.
27. Shnjoh M., Omoe K., Matuo N., Nerome K. In vitro growth profiles of respiratory syncytial virus in the presence of influenza virus. Acta Virol. 44:2000;91-97.
28. Sigurs N., Bjarnason R., Swigurbergsson F., Kjelman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:2000;150-157.
29. Sigurs N. Epidemiological and clinical evidence of a respiratory syncytial virus reactive airway disease link. Am. J. Respir. Crit. Care Med. 163:2001;S2-S6.
30. Sigurs N. Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease. Respir. Res. 3:2002;S8-S14.
31. Townsend A.R., Gotch F.M. Cytotoxic T cells recognize fragments of the influenza nucleoproteins. Cell. 42:1985;457-467.
32. Townsend A.R., Rothbad J., Gitch F.M., Bahadur G., Wraight D., McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell. 44:1986;959-968.
33. Waner J.L. Mixed viral infections: detection and management. Clin. Microbiol. Rev. 7:1994;143-151.